Malvina B. Eydelman, MD
Malvina B. Eydelman, MD is a board-certified ophthalmologist. She received her undergraduate degree in electrical engineering, with a focus on biomedical engineering, from The Cooper Union for the Advancement of Science and Art. She received her MD degree from Harvard Medical School and a Doctorate in health sciences and technology from Massachusetts Institute of Technology (M.I.T.). In 1995, Eydelman joined the Food and Drug Administration (FDA). For the past 20 years, as an expert medical officer, senior medical advisor, director of FDA's Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices (DONED) and director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices (DOED), Eydelman has played a key role in assuring the safety and effectiveness of ophthalmic medical devices. She has been actively involved in standardization of ophthalmic devices as the U.S. expert delegate to the International Standards Organization and FDA's liaison to the American National Standards Institute‘s Committee for Ophthalmic Devices. Eydelman has served as the principal investigator for several ophthalmic clinical and laboratory studies. She has spearheaded numerous initiatives designed to improve the safety and effectiveness of ophthalmic devices. Eydelman originated many symposia and workshops to facilitate ophthalmic device innovation. Her broad ophthalmic interests have resulted in a United States patent, numerous publications and many speaking engagements.
Hugh R. Taylor AC, MD, FRANZCO
Melbourne Laureate Professor Hugh R. Taylor AC is the Harold Mitchell Chair of Indigenous Eye Health at the University of Melbourne and president of the International Council of Ophthalmology. His work focuses on the provision of eye care and improving access to services including the elimination of trachoma. He has written 36 books and reports and more than 600 scientific papers. He has received multiple international awards and prizes. In 2001, he was made a Companion in the Order of Australia. Taylor first attended a meeting of the Association for Research in Vision and Ophthalmology (ARVO) in 1978. In 2002, he was the recipient of ARVO’s Mildred Weisenfeld Award for Excellence in Ophthalmology.
Robyn Ward, MBBS, PhD
Robyn Ward, MBBS, PhD, serves as deputy vice-chancellor (research) and acting executive dean of medicine at the University of Queensland. She is also visiting medical officer (oncology) at Princess Alexandra Hospital, Brisbane. Ward has over 20 years of experience in lab-based, clinical and health services research. As an oncologist, her particular clinical interests have been in the medical management of colorectal cancer, hereditary cancer and the rational use of cancer therapeutics.
Previously, Ward was UNSW chair of medicine at Prince of Wales Hospital and director of the Cancer Centre at Prince of Wales Hospital. Since 2010, she has driven The Bright Alliance, a $120 million construction consisting of the Nelune Comprehensive Cancer Centre, the Scientia Clinical Research facility (SCR) for phase one clinical trials and the Sydney Children’s Hospital research centre. Ward has long been a strong proponent for gender equity in science; she leads the University of Queensland component of Australia’s major gender equity program, Science in Australia Gender Equity.
Ward is the inventor and director of eviQ, a nationally-endorsed web-based system for the display of cancer treatment protocols that now has 31,500 registered users from 140 countries and over 2,000 cities. She has a longstanding interest in the future of academic medicine, and is passionate about the central role of the medical practitioner in the enterprise of health and medical research. In 2013, Ward was elected to the Council and Executive of the Australian Academy of Health and Medical Sciences, and she was made Member of the Order of Australia (AM) for significant service to patient care in the field of oncology.